Posts by Muana Minkoué
Agora Care celebrates 10’000 patients and a new collaboration with Caduceo
The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform. This marks an inflection point of the acceleration of Agora Care patient recruitment from early pilot projects to extended recruitment in several large radiology and healthcare networks in Switzerland. Agora Care is developing a patient-centered platform for storage and communication…
Read MoreFONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects
A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant of CHF 50,000 has been awarded to HUG project SmellRS. The FIF supports innovative technological startups and scale-ups at different stages of their journey with three types of financing options: the FIF Grant…
Read MoreArtiria Medical successfully secures USD 6 Million
Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first in-human results and FDA clearance. The MedTech company, developing next-generation neuro-interventional products for stroke and aneurysms, successfully closed off a Series A2 round of USD 0.6 Million. Furthermore, they secured an additional USD…
Read MoreLeenaards Prize awarded to two CHUV research groups
The two Leenards scientific prizes were awarded to research groups led by CHUV researchers. Each year, the Leenards Foundation awards scientific prizes for projects combining basic and clinical research, carried out by research groups in the Lake Geneva region. For 2024, a total of nearly CHF 1.4 million has been awarded to the…
Read MoreNewBiologix announced a licensing agreement with Florabio AS
NewBiologix SA announced a licensing agreement with Florabio AS to genetically engineer their proprietary HEK293 cell line. NewBiologix’s innovative approach stands to replace the industry-standard transient transfection methods, offering a stable, more reliable, and scalable solution for biopharmaceutical companies developing gene therapies. Under the terms of the agreement, NewBiologix acquired rights to use…
Read MoreAktiia secures CHF 27 Million
The Neuchâtel-based startup secures CHF 27 Million (USD 30M) in funding from Khosla Ventures and Others. Aktiia mission to revolutionise blood pressure monitoring has gained momentum with the successful closing of our CHF 27 million (USD 30 million) funding round, which was led by Redalpine and included participation from an international investor syndicate…
Read MoreFuture of Health Grant unveils its March 2024 cohort
Startups Resilient SA and Maven Health are among the eight new startups selected by the Future of Health Grant (FoHG) programme. Launched in 2022 by CSS and EPFL Innovation Park to support innovation in digital health, the programme received over 130 applications in its latest call for applications. The eight selected startups will receive…
Read MoreArgá Medtech SA closes oversubscribed Series B
Argá Medtech announces €54 Million oversubscribed series B capital raise. The round was led by the existing investors, Advent Life Sciences (UK) and Earlybird Health (Germany), as well as new investor Gilde Healthcare (the Netherlands) and an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative CSE™…
Read MoreTwo life sciences startups shortlisted for the 31st Prix Strategis
Testmate Health and Seprify are among the eight semi-finalists of this year’s Prix Strategis. Every year for almost 30 years, HEC Espace Entreprise has awarded the Prix Strategis to some of the most promising Swiss start-up with a prize of CHF 50’000. The Strategis Prize is a springboard for young companies with high…
Read MoreAbionic appoints Patrick Pestalozzi as new CEO to propel company into next growth phase
Abionic SA, a Swiss leader in nanofluidic point-of-care diagnostic solutions, announced the appointment of Patrick Pestalozzi as its new CEO, effective 1 April 2024. A former Management Consultant, Silicon Valley executive, and entrepreneur, Patrick brings to Abionic three decades of global experience. In particular, he previously acted as the Vice-President of Global Strategic…
Read More